Potential of CRISPR/Cas system as emerging tools in the detection of viral hepatitis infection

Area of Science:

• Hepatology and Virology
• Molecular Diagnostics
• Biotechnology

Background:

• Viral hepatitis, a leading cause of liver inflammation, impacts millions globally, primarily caused by hepatitis A-E viruses.
• Hepatitis B (HBV) and C (HCV) can lead to chronic infections, while hepatitis A (HAV) and E (HEV) are typically acute and self-limiting.
• Current diagnostic methods lack genetic-level accuracy, hindering timely therapeutic intervention despite existing vaccines and treatments.

Purpose of the Study:

• To review recent advancements in CRISPR-Cas diagnostic tools for viral hepatitis.
• To assess the potential and prospects of CRISPR-Cas technology in viral hepatitis diagnosis and control.
• To highlight the application of CRISPR-Cas in versatile point-of-care (POC) diagnostic settings.

Main Methods:

• Review of current literature on CRISPR-Cas systems and their application in viral disease diagnostics.
• Analysis of CRISPR-Cas specificity and sensitivity for detecting viral genomes (DNA and RNA).
• Evaluation of potential for point-of-care (POC) diagnostic applications.

Main Results:

• CRISPR-Cas technology demonstrates high specificity and sensitivity for detecting viral pathogens.
• Its versatility allows for the detection of both DNA and RNA viruses associated with hepatitis.
• CRISPR-Cas systems show significant potential for rapid, point-of-care diagnostic applications.

Conclusions:

• CRISPR-Cas technology presents a significant advancement in meeting the need for accurate genetic-level diagnosis of viral hepatitis.
• These tools offer prospects for rapid and effective strategies in the diagnosis and control of viral hepatitis infections.
• The development of CRISPR-Cas based diagnostics can revolutionize viral hepatitis management through accessible POC testing.